← Evidence map

ReviewLeukemia2021

Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations.

Roland B Walter et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

48 papers cite it

2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33758317